A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
Middle East respiratory syndrome coronavirus (MERS-CoV) has caused fatal infections, some through hospital-acquired transmission, in affected regions since its emergence in 2012. Although the virus is not pandemic among humans, it poses a great threat to public health due to its zoonotic origin. Thu...
Gardado en:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis Group
2017-01-01
|
| Series: | Emerging Microbes and Infections |
| Assuntos: | |
| Acceso en liña: | https://www.tandfonline.com/doi/10.1038/emi.2017.18 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|